The CCHFVACIM Kick-Off Meeting aimed to establish the project’s foundational framework, ensuring effective collaboration among consortium members to advance research and innovation in combating Crimean-Congo hemorrhagic fever.
The CCHFVACIM project will employ deep structural biology studies on viral glycoproteins, investigation of immunogenicity of viral antigens, and optimization of an mRNA vaccine candidate against CCHFV. Additionally, the project will focus on the development of immunotherapeutic monoclonal antibodies (mAbs) targeting CCHFV’s antigenic targets.
Full press release is available here
